MiNK Therapeutics Ownership | Who Owns MiNK Therapeutics?


OverviewForecastFinancialsChartTranscripts

MiNK Therapeutics Ownership Summary


MiNK Therapeutics is owned by 2.05% institutional investors, 74.60% insiders, and 23.35% retail investors. Vanguard group is the largest institutional shareholder, holding 0.59% of INKT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.38% of its assets in MiNK Therapeutics shares.

INKT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMiNK Therapeutics2.05%74.60%23.35%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group234.18K0.59%$163.22K
Longbow finance sa166.67K0.42%$116.15K
Renaissance101.71K0.26%$70.88K
Blackrock87.20K0.25%$82.77K
Geode capital management96.11K0.24%$67.00K
Blackrock funding, inc. /de88.28K0.22%$61.52K
Hightower advisors50.68K0.13%$35.32K
State street25.52K0.06%$17.78K
Goldman sachs group17.56K0.05%$16.67K
Millennium management13.12K0.04%$12.45K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Longbow finance sa166.67K0.01%$116.15K
Greenwich wealth management10.80K0.00%$8.00K
Covestor1.05K0.00%$1.00K
Renaissance101.71K0.00%$70.88K
Tower research capital llc (trc)5.40K0.00%$3.76K
Game plan financial advisors170.000.00%$116.00
Two sigma securities---
Assetmark---
Advisor group1.43K-$1.01K
Susquehanna group, llp---

Top Buyers

HolderShares% AssetsChange
Blackrock87.20K-11.05K
Goldman sachs group17.56K-1.93K
Tower research capital llc (trc)5.40K0.00%1.37K
Bnp paribas arbitrage, snc247.00-247.00
Jpmorgan chase325.00-196.00

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp---29.83K
Citadel advisors---20.81K
Captrust financial advisors---15.32K
Two sigma securities---11.94K
Millennium management13.12K--6.98K

New Positions

HolderShares% AssetsChangeValue
Bnp paribas arbitrage, snc247.00-247.00$172.00
Fmr1.00-1.00$1.00

Sold Out

HolderChange
Jaffetilchin investment partners-1.00
Assetmark-1.00
Harbor investment advisory-5.00
Lifesteps financial-28.00
Rhumbline advisers-48.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202423-11.54%809,544-4.38%244.65%6-33.33%6-14.29%
Sep 30, 202426-13.33%846,639-5.78%231.83%9-7-30.00%
Jun 30, 202430-9.09%898,529-4.07%234.90%928.57%10-16.67%
Mar 31, 202433-8.33%936,697-5.46%233.05%7-46.15%1220.00%
Dec 31, 2023362.86%990,80336.95%264.97%1362.50%10-41.18%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv15.15K0.38%327.00
Vanguard Institutional Extnd Mkt Idx Tr8.60K0.22%-
Fidelity Extended Market Index5.48K0.14%-35.00
iShares Micro-Cap ETF2.23K0.06%-
Fidelity Nasdaq Composite Index1.90K0.05%-
Fidelity Series Total Market Index1.17K0.03%-
BlackRock Extended Equity Market K8.48K0.02%-4.00
Extended Equity Market Fund K838.000.02%2.00
Northern Trust Extended Eq Market Idx7.31K0.02%-
NT Ext Equity Mkt Idx Fd - L731.000.02%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 16, 2023AGENUS INC-Buy$471.56
Oct 12, 2023AGENUS INC-Buy$3.49K
Oct 13, 2023AGENUS INC-Buy$21.31K
Oct 04, 2023AGENUS INC-Buy$16.38K
Aug 29, 2023AGENUS INC-Buy$45.02K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

INKT Ownership FAQ


Who Owns MiNK Therapeutics?

MiNK Therapeutics shareholders are primarily institutional investors at 2.05%, followed by 74.60% insiders and 23.35% retail investors. The average institutional ownership in MiNK Therapeutics's industry, Biotech Stocks , is 68.48%, which MiNK Therapeutics falls below.

Who owns the most shares of MiNK Therapeutics?

MiNK Therapeutics’s largest shareholders are Vanguard group (234.18K shares, 0.59%), Longbow finance sa (166.67K shares, 0.42%), and Renaissance (101.71K shares, 0.26%). Together, they hold 1.27% of MiNK Therapeutics’s total shares outstanding.

Does Blackrock own MiNK Therapeutics?

Yes, BlackRock owns 0.25% of MiNK Therapeutics, totaling 87.2K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 82.77K$. In the last quarter, BlackRock increased its holdings by 11.05K shares, a 14.51% change.

Who is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested?

Longbow finance sa is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 166.67K MiNK Therapeutics shares, valued at 116.15K$.

Who is the top mutual fund holder of MiNK Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MiNK Therapeutics shares, with 0.38% of its total shares outstanding invested in 15.15K MiNK Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools